https://www.selleckchem.com/pr....oducts/Deforolimus.h
005). Advanced age, earlier year of diagnosis, lack of insurance or Medicaid, and higher comorbidity were associated with poor survival (HR1), whereas female sex, non-Hispanic black race, higher income, and treatment at an academic center were associated with improved survival (HR1). Disparities in treatment of MM exist and are caused by a complex interplay of multiple factors, with socioeconomic factor playing a significant role. Studies exploring such determinants may help in equitable distribution of resources to overcome
Like
Comment
Share
